Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Canan Demirustu is active.

Publication


Featured researches published by Canan Demirustu.


Phytomedicine | 2008

Effects of carvacrol on defects of ischemia-reperfusion in the rat liver.

Mediha Canbek; Mustafa Uyanoglu; Gokhan Bayramoglu; Hakan Senturk; Nilüfer Erkasap; Tulay Koken; Sema Uslu; Canan Demirustu; Erinc Aral; K. Hüsnü Can Başer

Many plants found in nature have been used to treat various illnesses. One such plant is oregano (Kekik in Turkish). Health beneficial effects of carvacrol obtained from oregano oil have been shown scientifically. We have investigated the comparative effects of carvacrol in the liver of rats subjected to ischemia-reperfusion defect, with silymarin. To test the effects we formed four groups using male Wistar albino rats. Group I was control. The other three groups of animals were administered 60min prior to surgical operation single doses of physiological serum, carvacrol and silymarin, respectively. Group II, III and IV animal were subjected to 45min long liver ischemia and 60min reperfusion. Blood and tissue samples were collected for biochemical and histological analysis following the test. AST and ALT values obtained after biochemical analysis of the serums showed statistically significant difference in group II than the other three groups. A statistical evaluation of the serum AST levels among the groups II, III and IV showed that both groups III and IV which had no difference in between were significantly different in a positive way from group II (p<0.001). As to the serum ALT levels, difference between group II and group III (p<0.001) and group II and group IV (p<0.01) was found significant. No statistical difference was observed in groups I, III and IV for GSH, MDA and CAT levels of the liver. A statistical evaluation of the GSH level in group III and group IV was found to be significantly different from group II (p<0.001) without any difference between them. A similar evaluation for MDA and CAT levels among the revealed no difference between group III and group IV, however, group II showed difference with group II and group IV (p<0.05). Histological findings were in harmony with the biochemical results. We conclude that carvacrol protects the liver against defects caused by ischemia and reperfusion, and carvacrol is not hepatotoxic at the applied dosage.


Neurochemical Research | 2012

Levels of Amyloid Beta-42, Interleukin-6 and Tumor Necrosis Factor-Alpha in Alzheimer’s Disease and Vascular Dementia

Sema Uslu; Zubeyde Eken Akarkarasu; Demet Ozbabalik; Serhat Özkan; Omer Colak; Emine Sütken Demirkan; Ayşe Ozkiris; Canan Demirustu; Ozkan Alatas

Amyloid β42 (Aβ42) and proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) have been suggested to contribute to the pathogenesis of Alzheimer’s disease (AD) and vascular dementia (VaD). Our aim was to examine whether the changes in these parameters would be able to discriminate the patients with AD from those with VaD and from healthy individuals. We have analyzed the levels of Aβ42, IL-6 and TNF-α in the serum of newly diagnosed 28 AD patients, 16 VaD patients and 26 healthy non-demented controls. We also investigated whether there is an association between Aβ42, IL-6 and TNF-α levels and mini-mental state examination (MMSE) scores and body mass indexes (BMI) of patients. Our data showed a significant decrease in serum Aβ-42 levels in AD patients compared to VaD patients and controls. Levels of IL-6 and TNF-α were not different between AD patients, VaD patients and controls. We observed a correlation between Aβ-42 levels and MMSE scores and BMI levels in both AD and VaD patients. However, Aβ-42 levels were not correlated with IL-6 and TNF-α levels. Significantly lower levels of Aβ42 found in the serum of AD patients than that of VaD patients and controls suggests that it can be a specific biochemical marker for AD.


Chinese Journal of Physiology | 2010

Protective Effects of Leptin on Ischemia/Reperfusion Injury in Rat Bladder

Mehmet Hamarat; Aydın Yenilmez; Nilüfer Erkasap; Burhanettin Işıklı; Erinc Aral; Tulay Koken; Cavit Can; Canan Demirustu

The aim of the study was to evaluate protective effects of exogenous leptin on ischemia/reperfusion (I/R)-induced injuries to the urinary bladder tissue and to investigate the effect on tumor necrosis factor alpha (TNF-alpha) levels and apoptotic cells during I/R injury. Bladder I/R injury was induced by abdominal aorta occlusion by ischemia for 45 min, followed by 60 min of reperfusion in rats. The rats were divided into three groups: control (n = 8 + 8), I/R (n = 8 + 8) and I/R+leptin group (n = 8 + 8). The rats in the I/R+leptin group were treated intraperitoneally with leptin (10 microg/kg) 60 min prior to ischemia induction. At the end of the reperfusion period, urinary bladders of the first eight rats from each group were removed for TUNEL staining processing while the others were removed for biochemical analyses for MDA and TNF-alpha levels. In the I/R group, the ratios of TUNEL-positive nuclei were higher than the control and the I/R+leptin groups. The MDA and TNF-alpha levels of the bladder tissue in the I/R group were higher than the control and leptin-treated groups. TUNEL-staining and biochemical studies revealed that leptin has a protective effect on urinary bladder I/R injury.


The Anatolian journal of cardiology | 2012

Diagnostic value of heart-type fatty acid binding protein determined by the rapid qualitative chromatographic immunoassay method for the detection of minor myocardial damage in patients presenting with non-ST elevation acute coronary syndrome.

Yuksel Cavusoglu; Bülent Gök; Canan Demirustu; Alparslan Birdane; Bulent Gorenek; Necmi Ata

OBJECTIVE The aim of this prospective study was to evaluate the diagnostic value of heart-type fatty acid binding protein (H-FABP) determined by qualitative immunoassay method for the detection of minor myocardial damage (MMD) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). METHODS The study consisted of 62 patients with NSTE-ACS. Cardiac troponin I (cTnI) and creatine kinase MB isoenzyme (CK-MB) values were measured at arrival. Myoglobin and H-FABP were obtained if cTnI level was found to be elevated. A control group included 20 subjects with normal cTnI and CK-MB values. H-FABP was determined by a rapid qualitative immunochromatographic test. Patients were classified as MMD-ACS group if they had abnormal cTnI and normal CK-MB (n=24) and as NSTEMI-ACS group if they had elevated both cTnI and CK-MB (n=38). The diagnostic accuracy of H-FABP for minor myocardial damage was determined using ROC analysis. RESULTS The sensitivity of the H-FABP was significantly higher for NSTEMI-ACS than for MMD-ACS (44.7% vs 0%, p<0.001) and its specificity was 95% for both groups. The diagnostic efficacy rates for myoglobin and H-FABP were 75% and 43% for MMD-ACS, 74% and 62% for NSTEMI-ACS. Positive predictive value for H-FABP and myoglobin were found to be 0% and 80.8% in MMD-ACS, 94% and 87% in NSTEMI-ACS and negative predictive value was 44% and 69.5% in MMD-ACS, 47.5% and 59% in NSTEMI-ACS, respectively. AUC for myoglobin was significantly greater than that for H-FABP in MMD-ACS group (0.754 vs 0.525, p=0.027). The sensitivity of the H-FABP was significantly higher in patients with >3-fold increase in cTnI than those with <3-fold increase in cTnI (46.8% vs. 6.7%, p<0.001). A positive correlation was found between the magnitude of cTnI rise and H-FABP results (r=0.45, p<0.001). CONCLUSIONS H-FABP determined by the rapid qualitative immunochromatographic test has almost similar diagnostic value to that of myoglobin for identifying NSTEMI-ACS, however, does not seem to represent diagnostic potential for the detection of MMD.


International Journal of Cardiology | 2008

Both levosimendan and dobutamine treatments result in significant reduction of NT-proBNP levels, but levosimendan has better and prolonged neurohormonal effects than dobutamine

Yuksel Cavusoglu; Mujgan Tek; Alparslan Birdane; Necmi Ata; Canan Demirustu; Bulent Gorenek; Ahmet Unalir; Bilgin Timuralp


Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır | 2010

[Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].

Mujgan Tek; Yuksel Cavusoglu; Canan Demirustu; Alparslan Birdane; Ahmet Unalir; Bulent Gorenek; Omer Goktekin; Necmi Ata


The FASEB Journal | 2014

The effects of alpha lipoic acid on apoptosis, NF-κB and iNOS mRNA expression in experimental colitis (902.3)

Mete Özkurt; İlhan Zencirci; Fatih Necdet; Nilüfer Erkasap; Murat Tosun; Canan Demirustu; Enver İhtiyar; Serdar Erkasap


Archive | 2008

Letter to the Editor Levosimendan-induced reduction in natriuretic peptide levels during the treatment of decompensated heart failure: Clinical implications — Reply

Yuksel Cavusoglu; Mujgan Tek; Canan Demirustu


International Journal of Cardiology | 2008

Levosimendan may provide a better neurohormonal response in heart failure patients receiving beta blocker therapy — Reply

Yuksel Cavusoglu; Mujgan Tek; Canan Demirustu


International Journal of Cardiology | 2008

Levosimendan-induced reduction in natriuretic peptide levels during the treatment of decompensated heart failure: Clinical implications — Reply

Yuksel Cavusoglu; Mujgan Tek; Canan Demirustu

Collaboration


Dive into the Canan Demirustu's collaboration.

Top Co-Authors

Avatar

Mujgan Tek

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Bulent Gorenek

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Necmi Ata

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Yuksel Cavusoglu

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Ahmet Unalir

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Alparslan Birdane

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Nilüfer Erkasap

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar

Yuksel Cavusoglu

Eskişehir Osmangazi University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sema Uslu

Eskişehir Osmangazi University

View shared research outputs
Researchain Logo
Decentralizing Knowledge